EUVIMEDOpdag EUVIMED
Editorial

Editorial: Therapeutic Drug Monitoring of Infliximab During Induction Therapy in IBD —Is This the Time for Model Informed Precision Dosing?

Benjamin Mecsas-Faxon, Konstantinos Papamichael iD, Adam S Cheifetz iD

Alimentary Pharmacology & Therapeutics · 2026-11-04

DOI: 10.1111/apt.71087 ↗

At a glance

Editorial in Alimentary Pharmacology & Therapeutics, published online on 2026-11-04. Written by Benjamin Mecsas-Faxon and 2 co-authors. Institution: Center for Inflammatory Bowel Diseases, Division of Gastroenterology, Beth-Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachus…. 28 references.

AbstractBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Intet abstract tilgængeligt.

Authors and institutions

  • Center for Inflammatory Bowel Diseases, Division of Gastroenterology, Beth-Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, USA.

ORCID profiles: Konstantinos Papamichael, Adam S Cheifetz

Cite

APA

Mecsas-Faxon, B., Papamichael, K., & Cheifetz, A. S. (2026). Editorial: Therapeutic Drug Monitoring of Infliximab During Induction Therapy in IBD —Is This the Time for Model Informed Precision Dosing?. Alimentary Pharmacology & Therapeutics. https://doi.org/10.1111/apt.71087

Vancouver

Mecsas-Faxon B, Papamichael K, Cheifetz AS. Editorial: Therapeutic Drug Monitoring of Infliximab During Induction Therapy in IBD —Is This the Time for Model Informed Precision Dosing?. Alimentary Pharmacology & Therapeutics. 2026. doi:10.1111/apt.71087

BibTeX
@article{MecsasFaxon2026,
  author = {Mecsas-Faxon, Benjamin and Papamichael, Konstantinos and Cheifetz, Adam S},
  title = {Editorial: Therapeutic Drug Monitoring of Infliximab During Induction Therapy in IBD —Is This the Time for Model Informed Precision Dosing?},
  journal = {Alimentary Pharmacology & Therapeutics},
  year = {2026},
  doi = {10.1111/apt.71087}
}
Start for free →